BHRT pellets vs creams vs patches: which is best and who offers them?

Short answer

• There’s no one “best” BHRT delivery method — the right choice depends on your goals, medical history, tolerance for procedures, and how closely you want dose control.
• Broadly: pellets = long‑lasting, low‑maintenance but less easy to adjust and require a minor procedure; creams/gels = easy topical use but variable absorption; patches = steady, adjustable dosing with generally reliable absorption and simple stop/start.

Detailed comparison

1. Pellets (subcutaneous implants)

• What they are: small bioidentical hormone (usually estradiol ± testosterone) pellets inserted under the skin every 3–6 months.
• Pros: sustained, steady hormone release; no daily dosing; can improve adherence and reduce daily symptom fluctuations.
• Cons: requires an office procedure to insert/remove; dose cannot be quickly turned off; some people get infections, pellet extrusion, or local irritation; evidence from large randomized trials is limited.
• Common providers/brands: BioTE Medical (widely used training/network), SottoPelle (international franchise), various compounding pharmacies also make pellets (local compounding clinics). These are often offered through specialized BHRT clinics, some OB/GYNs, and anti‑aging/functional medicine practices.

1. Topical creams/gels/sprays

• What they are: estradiol or progesterone applied to the skin; includes compounded “bioidentical” creams and FDA‑approved gels. Sprays (transdermal) also exist.
• Pros: easy to start/stop and change dose; can be targeted to skin; good for people who want noninvasive, flexible dosing.
• Cons: absorption varies by site/skin condition, can transfer to others by skin contact, dosing less predictable (especially with compounded creams).
• Examples: FDA‑approved gels include EstroGel and Divigel (estradiol gel); Evamist (estradiol transdermal spray). Compounded bioidentical creams are available from many compounding pharmacies (e.g., Wedgewood, Empower Pharmacy and other PCCA‑affiliated local pharmacies), but quality and concentrations vary.

1. Transdermal patches

• What they are: adhesive patches that deliver estradiol (with some products combining progestin) applied to skin and changed every few days.
• Pros: steady, predictable absorption; easy to stop/change dose; lower first‑pass liver effects than oral estrogen (may reduce some risks); widely studied.
• Cons: some people get skin irritation; must remember to change patch on schedule.
• Common brands: Vivelle‑Dot (estradiol), Climara (estradiol), Alora/Minivelle, Menostar (lower dose for fracture prevention). These are FDA‑approved (dose and formulation vary).

Safety, evidence, and “bioidentical” labeling

• “Bioidentical” means the hormone molecule is chemically identical to human hormones (e.g., 17β‑estradiol, micronized progesterone). Many FDA‑approved estradiol and progesterone products are bioidentical. Compounded products often market as “bioidentical” but aren’t FDA‑regulated the same way and can vary in dose/purity.
• Risks and benefits depend more on hormone type, dose, route, and your health history (age, time since menopause, blood clot or heart disease risk, uterine status). Transdermal patches/gels are thought to have a lower VTE risk than oral estrogen in some studies; pellets are systemic and carry similar systemic risks to other systemic routes but are less studied in large RCTs.

How to choose (practical guidance)

• If you want minimal daily management and accept a minor procedure: consider pellets (BioTE, SottoPelle) — but discuss dose flexibility and follow‑up.
• If you want easy dose adjustment, quick stop capability, and predictable transdermal delivery: patches (Vivelle‑Dot, Climara) are a good choice.
• If you want noninvasive, localized application and are comfortable monitoring symptoms/labs: gels/creams (EstroGel, Divigel, or a supervised compounded cream) or spray (Evamist) can be used.
• Discuss with a clinician who will review your medical history, check baseline labs, consider whether you need progesterone (if you have a uterus), and set a monitoring plan. Ask whether the product is FDA‑approved or compounded, how they verify potency/safety, and what the cost/insurance coverage will be.

Next steps

• See an OB‑GYN, endocrinologist, or a licensed clinician experienced in menopause/BHRT.
• If you’re considering pellets, ask the clinic about insertion technique, complication rates, and how they handle dose adjustments or adverse effects. If you’re considering compounded products, ask for pharmacy credentials (PCCA membership, testing procedures).
• If you want, tell me your main priorities (e.g., avoid daily dosing, want rapid control of symptoms, worried about blood clot risk, have a uterus) and I can give a more tailored comparison and name the most suitable options.